Forefront Analytics, LLC
- SEC CIK
- 0001696802
- Latest filing
- Aug 12, 2026
Holdings changes from Q4 2025 to Q1 2026
Long positions only; new, added, reduced and sold out are based on share counts. Pick any two quarters this institution filed.
- New
- 4
- Est. +$1.34M
- Added
- 21
- Est. +$12.2M
- Reduced
- 14
- Est. −$13.0M
- Sold out
- 8
- Est. −$4.81M
Portfolio value went from $113.3M to $110.0M (−$3.31M (−2.9%)); positions from 43 to 39 (−4).
All Q1 2026 holdingsAll Q4 2025 holdings
In the shares, value and % of portfolio columns, the top figure is Q1 2026 and the gray one below is Q4 2025. For stocks that split between the two quarters, Q4 2025 shares are converted at the split ratio before comparing.
| Security | Action | Shares | Share change | Value | Est. bought or sold | % of portfolio | Weight change (pp) |
|---|---|---|---|---|---|---|---|
| iShares Tr46435G516 | Added– | 254,427211,190 | +43,237+20.5% | $24.3M$20.1M | +$4.13M | 22.1%17.7% | +4.40 |
| iShares Inc46434G863 | Added– | 369,453363,728 | +5,725+1.6% | $16.8M$16.1M | +$260.3K | 15.3%14.2% | +1.09 |
| Vanguard Ftse Emerging Markets ETF922042858 | Reduced– | 180,162181,105 | −943−0.5% | $9.74M$9.74M | −$51.0K | 8.9%8.6% | +0.26 |
| iShares Core High Dividend ETF46429B663 | Reduced– | 68,08769,308 | −1,221−1.8% | $9.24M$8.43M | −$165.7K | 8.4%7.4% | +0.96 |
| Nushares ETF Tr67092P300 | Added– | 195,657141,379 | +54,278+38.4% | $8.90M$6.37M | +$2.47M | 8.1%5.6% | +2.47 |
| Flexshares Tr33939L688 | Added– | 44,23922,999 | +21,240+92.4% | $8.84M$4.72M | +$4.25M | 8.0%4.2% | +3.87 |
| DBX ETF Tr233051200 | Reduced– | 126,892127,851 | −959−0.8% | $6.27M$6.15M | −$47.4K | 5.7%5.4% | +0.27 |
| iShares MSCI USA Momentum Factor ETF46432F396 | Reduced– | 24,23450,646 | −26,412−52.2% | $5.82M$12.7M | −$6.34M | 5.3%11.2% | −5.90 |
| Vanguard Ftse Developed Markets ETF921943858 | Reduced– | 47,307123,208 | −75,901−61.6% | $3.03M$7.70M | −$4.86M | 2.8%6.8% | −4.04 |
| iShares Core S&P 500 ETF464287200 | Reduced– | 4,4744,707 | −233−5.0% | $2.92M$3.22M | −$152.2K | 2.7%2.8% | −0.19 |
| NVDANVIDIA Corp | AddedHistory | 14,24113,976 | +265+1.9% | $2.48M$2.61M | +$46.2K | 2.3%2.3% | −0.04 |
| iShares Inc46434G509 | Reduced– | 58,54060,169 | −1,629−2.7% | $2.16M$2.09M | −$60.1K | 2.0%1.8% | +0.12 |
| JPMJPMorgan Chase & Co | AddedHistory | 4,9843,353 | +1,631+48.6% | $1.47M$1.08M | +$479.8K | 1.3%1.0% | +0.38 |
| DEDeere & Co | AddedHistory | 1,1361,133 | +3+0.3% | $640.2K$528.0K | +$1.69K | 0.6%0.5% | +0.12 |
| UNHUnitedHealth Group Inc | AddedHistory | 1,9831,452 | +531+36.6% | $536.6K$479.2K | +$143.7K | 0.5%0.4% | +0.06 |
| EWEdwards Lifesciences Corp | AddedHistory | 6,5746,113 | +461+7.5% | $526.4K$521.1K | +$36.9K | 0.5%0.5% | +0.02 |
| ABTAbbott Laboratories | AddedHistory | 5,0433,756 | +1,287+34.3% | $517.7K$470.6K | +$132.1K | 0.5%0.4% | +0.06 |
| WisdomTree Tr97717W562 | Reduced– | 8,23217,760 | −9,528−53.6% | $477.9K$1.01M | −$553.1K | 0.4%0.9% | −0.46 |
| Schwab US Dividend Equity ETF808524797 | New– | 15,1190 | +15,119 | $463.9K$0 | +$463.9K | 0.4%0.0% | +0.42 |
| MDTMedtronic plc | AddedHistory | 5,3194,280 | +1,039+24.3% | $460.9K$411.1K | +$90.0K | 0.4%0.4% | +0.06 |
| ProShares Tr74347R107 | Added– | 8,1648,146 | +18+0.2% | $423.6K$471.8K | +$933.87 | 0.4%0.4% | −0.03 |
| INCYIncyte Corp | ReducedHistory | 4,2335,198 | −965−18.6% | $398.4K$513.4K | −$90.8K | 0.4%0.5% | −0.09 |
| ProShares Tr74347R842 | Added– | 7,9907,977 | +13+0.2% | $372.9K$375.1K | +$606.72 | 0.3%0.3% | +0.01 |
| PFEPfizer Inc | ReducedHistory | 13,09019,104 | −6,014−31.5% | $367.6K$475.7K | −$168.9K | 0.3%0.4% | −0.09 |
| OTFBlue Owl Technology Finance Corp. | NewHistory | 29,6540 | +29,654 | $367.4K$0 | +$367.4K | 0.3%0.0% | +0.33 |
| REGNRegeneron Pharmaceuticals, Inc. | AddedHistory | 460427 | +33+7.7% | $355.0K$329.4K | +$25.5K | 0.3%0.3% | +0.03 |
| TMOThermo Fisher Scientific Inc. | ReducedHistory | 579586 | −7−1.2% | $284.6K$339.5K | −$3.44K | 0.3%0.3% | −0.04 |
| LEGNLegend Biotech Corp | NewHistory | 15,6590 | +15,659 | $283.3K$0 | +$283.3K | 0.3%0.0% | +0.26 |
| Vanguard Morningstar Value ETF922908744 | Reduced– | 1,3173,465 | −2,148−62.0% | $258.5K$661.8K | −$421.6K | 0.2%0.6% | −0.35 |
| DHRDanaher Corp | AddedHistory | 1,288915 | +373+40.8% | $244.2K$209.4K | +$70.7K | 0.2%0.2% | +0.04 |
| PMPhilip Morris International Inc. | AddedHistory | 1,4501,437 | +13+0.9% | $239.7K$230.0K | +$2.15K | 0.2%0.2% | +0.01 |
| Dimensional ETF Trust25434V815 | New– | 6,3410 | +6,341 | $222.2K$0 | +$222.2K | 0.2%0.0% | +0.20 |
| NKTXNkarta, Inc. | AddedHistory | 43,83540,702 | +3,133+7.7% | $92.5K$75.3K | +$6.61K | 0.1%0.1% | +0.02 |
| ZURAZura Bio Ltd | ReducedHistory | 14,90119,577 | −4,676−23.9% | $88.7K$102.6K | −$27.8K | 0.1%0.1% | −0.01 |
| GERNGeron Corp | AddedHistory | 55,12551,320 | +3,805+7.4% | $82.1K$67.7K | +$5.67K | 0.1%0.1% | +0.01 |
| ANNXAnnexon, Inc. | AddedHistory | 14,24013,226 | +1,014+7.7% | $78.9K$66.4K | +$5.62K | 0.1%0.1% | +0.01 |
| BCYCBicycle Therapeutics PLC | AddedHistory | 14,39413,371 | +1,023+7.7% | $66.8K$94.7K | +$4.75K | 0.1%0.1% | −0.02 |
| CTMXCytomX Therapeutics, Inc. | ReducedHistory | 12,47618,699 | −6,223−33.3% | $58.6K$79.7K | −$29.2K | 0.1%0.1% | −0.02 |
| MREOMereo BioPharma Group plc | AddedHistory | 127,77831,768 | +96,010+302.2% | $42.2K$13.2K | +$31.7K | <0.1%<0.1% | +0.03 |
| iShares Tr464289883 | Sold out– | 058,682 | −58,682−100.0% | $0$2.35M | −$2.35M | 0.0%2.1% | −2.08 |
| First Tr Exchange-Traded FD33738D101 | Sold out– | 018,435 | −18,435−100.0% | $0$698.0K | −$698.0K | 0.0%0.6% | −0.62 |
| iShares Tr464288661 | Sold out– | 04,740 | −4,740−100.0% | $0$566.0K | −$566.0K | 0.0%0.5% | −0.50 |
| iShares Tr464288513 | Sold out– | 03,290 | −3,290−100.0% | $0$265.0K | −$265.0K | 0.0%0.2% | −0.23 |
| iShares Tips Bond ETF464287176 | Sold out– | 02,228 | −2,228−100.0% | $0$245.0K | −$245.0K | 0.0%0.2% | −0.22 |
| iShares Tr464288372 | Sold out– | 03,968 | −3,968−100.0% | $0$244.0K | −$244.0K | 0.0%0.2% | −0.22 |
| iShares Iboxx $ Investment Grade Corporate Bond ETF464287242 | Sold out– | 02,021 | −2,021−100.0% | $0$223.0K | −$223.0K | 0.0%0.2% | −0.20 |
| MIRMMirum Pharmaceuticals, Inc. | Sold outHistory | 02,663 | −2,663−100.0% | $0$210.3K | −$210.3K | 0.0%0.2% | −0.19 |
Estimated amounts multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares): new positions use this quarter's value and sold-out positions last quarter's; positions reported only as principal (PRN) cannot be estimated. 13F shows only quarter-end holdings, not when trades happened or at what price.